ARCHIVES

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

NCAB, Panel May Look A Discrepancies, In Study Section Evaluation Of Grant Applications

September 4, 1981

Hammer Says “Exciting Times” Should Convince President to Increase Budget, Ok Act Renewal

April 26, 1985

Mentholated Cigarettes Cause No More Lung Cancer, Deaths

March 25, 2011

In Brief: Katterhagen Committee to Meet On PDQ Questions; ACS Grants Total Highest In History, $57 Million

August 19, 1983

Conference On Delayed Consequences Of Cancer Therapy Scheduled Jan. 9-11

January 3, 1975

Breast Cancer Reports “Informative,” More Research Is Needed: Gullino

December 3, 1976